HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Previous close
$25.40
Day range
$24.79 - $25.42
Year range
$16.10 - $38.55
Market cap
3.14B USD
Avg Volume
2.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 178.49M | -10.61% |
Operating expense | 131.14M | 2.39% |
Net income | -42.15M | -11.93% |
Net profit margin | -23.61 | -25.19% |
Earnings per share | -0.33 | -14.50% |
EBITDA | -32.84M | -13.26% |
Effective tax rate | -1.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 374.78M | 1.83% |
Total assets | 821.39M | -9.19% |
Total liabilities | 665.08M | 3.89% |
Total equity | 156.30M | — |
Shares outstanding | 126.29M | — |
Price to book | 20.48 | — |
Return on assets | -10.22% | — |
Return on capital | -13.21% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -42.15M | -11.93% |
Cash from operations | 4.44M | 153.30% |
Cash from investing | -49.00K | 45.56% |
Cash from financing | 6.56M | -84.56% |
Net change in cash | 11.64M | -66.17% |
Free cash flow | 6.80M | 112.63% |
About
Founded
2009
Headquarters
Website
Employees
708
